This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Innovation & Partnering Summit
March 21-23, 2023
Delivered as a Hybrid EventPhiladelphia, PA

Wendy Erler
Vice President, Head Patient Advocacy at Alexion Pharmaceuticals


Wendy Erler is the Vice President of Patient Experience at Alexion Astra Zeneca, rare diseases, where she is responsible for leading the enterprise innovation model to gather and incorporate patient insights throughout the drug development and commercialization processes. She leads the Global Patient Experience function and has responsibility for driving the organization’s patient centricity strategy and leads the global patient advocacy team. Wendy has developed corporate frameworks and operating models to meaningfully embed patient insights and processes that enable patient centricity. She chairs the Alexion Ethics Advisory Board. Previously, Ms. Erler was on the executive leadership team at Wave Life Sciences where she led Patient Advocacy and Commercial. Wendy serves on the board of RARE-X and n-Lorem Advisory Committee.

Wendy graduated from Miami University and earned her MBA from St. Joseph’s University.

Agenda Sessions

  • Understand the Rare Disease Patient Journey — Actionable Insights from Discovery to Access